secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quanterix Corp (QTRX)
CIK:        0001503274
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001503274-25-000089
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quanterix Q2 revenue drops 29% to $24.5M; net loss widens to $30M; guides FY25 revenue $130-135M
--------------------------------------------------------------------------------

- GAAP net loss $30.0M vs $7.4M in Q2 2024; GAAP gross margin 46.2% vs 64.7%.
- Revenue $24.5M down 29% YoY; Alzheimer's Diagnostics revenue more than tripled.
- Closed Akoya acquisition in early July; $64M of $85M cost reduction target achieved.
- FY 2025 revenue guidance $130-135M (incl. ~2 quarters Akoya); pro forma $165-170M.
- Expects cash flow breakeven in 2026; exiting 2025 with ~$120M cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503274/000150327425000089/0001503274-25-000089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503274/000150327425000089/qtrx-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001503274-25-000089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer